Jorkar Pharmaceuticals Private Limited
About Jorkar Pharmaceuticals Private Limited
Data last updated:
Jorkar Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the real estate financing segment of the financial services sector. It was incorporated on 13 December 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2005PTC143593.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹43.61 Lakh. It is led by directors Manju Rani and Krishna Devi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No. 163A Ground Floor Shop No. 2 Shahpur Jat, Delhi, India – 110049.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.24 Lakh. For the same year it recorded a net profit of ₹59,787 (net margin 6.5%) and EBITDA of ₹2.11 Lakh (EBITDA margin 22.8%).
As per MCA filings, the company has open charges of ₹2.41 Cr and satisfied charges of ₹1.45 Cr on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Jorkar Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No. 163A Ground Floor Shop No. 2 Shahpur Jat, Delhi, India – 110049
- IndustryFinancial Services, Real Estate Financing, Equipment Leasing & Financing
To see the full contact details of Jorkar Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Jorkar Pharmaceuticals Private Limited
FY 2025 filings availableJorkar Pharmaceuticals Private Limited reported revenue of ₹9.24 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.11 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹59,787 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 22.8% | ||||
| Net Profit Margin | 6.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jorkar Pharmaceuticals Private Limited, buy the company report.
Board of directors of Jorkar Pharmaceuticals Private Limited
Jorkar Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manju Rani | Director | 11 Jun 2019 | 7 Years 4 Months | Current |
| Krishna Devi | Director | 12 Aug 2011 | 15 Years 2 Months | Current |
Peer comparison
Jorkar Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the BFSI industry (Machinery and Equipment Leasing, Pharmaceuticals, Real Estate Leasing), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Smooth Trading Private Limited | ₹9.25 Lakh (FY 2024) | -6.0% | Kolkata, West Bengal, India | |||
| Homelike Motels and Resorts Private Limited | ₹9.25 Lakh (FY 2025) | 0.0% | Lucknow, Uttar Pradesh, India | |||
| Satyaraj Warehousings Pvt Ltd. | ₹9.24 Lakh (FY 2025) | 62.0% | Kolkata, West Bengal, India | |||
| Sakambhari Merchandise Private Limited | ₹9.24 Lakh (FY 2016) | 0.0% | Kolkata, West Bengal, India | |||
| Everest Pharmaceuticals Pvt Ltd | ₹9.24 Lakh (FY 2025) | 5.0% | Kolkata, West Bengal, India | |||
| Jorkar Pharmaceuticals Private Limitedthis company | ₹9.24 Lakh (FY 2025) | ₹59,787 | 6.5% | Delhi, India | ||
| KKM Prefab Private Limited | ₹9.24 Lakh (FY 2025) | 9.0% | New Delhi, Delhi, India | |||
| Glez Pharmaceuticals Private Limited | ₹9.23 Lakh (FY 2022) | 18.0% | Gwalior, Madhya Pradesh, India | |||
| Arpit Limited | ₹9.22 Lakh (FY 2025) | -3.0% | Mumbai, Maharashtra, India | |||
| Adiyogi Properties Private Limited | ₹9.22 Lakh (FY 2018) | Chennai, Tamil Nadu, India | ||||
| Draylen Conglomerate Private Limited | ₹9.22 Lakh (FY 2024) | -18.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Jorkar Pharmaceuticals Private Limited, buy the company report.
Auditor
Jorkar Pharmaceuticals Private Limited is audited by M K NAGPAL & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M K NAGPAL & ASSOCIATES | FY 2019 | 013031N |
Shareholding
The shareholding of Jorkar Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Jorkar Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 May 2023 | 100755884 | Hdfc Bank Limited | ₹2.41 Cr | Open | |
| 12 Jun 2006 | 10007490 | Punjab National Bank | ₹55 Lakh | Satisfied | |
| 12 Jun 2006 | 10013134 | Punjab National Bank | ₹40 Lakh | Satisfied | |
| 12 Jun 2006 | 10079073 | Punjab National Bank | ₹50 Lakh | Satisfied |
To see the full charge records of Jorkar Pharmaceuticals Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
Jorkar Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Faridabad, Haryana | Court case (S C) | Filed against the company by State of Haryana/Drug Cont | Disposed |
To see the full case history of Jorkar Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jorkar Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Jorkar Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Jorkar Pharmaceuticals Private Limited has 5 board changes on record since 2011: 2 appointments and 3 cessations. The latest: Jai Pal Singh ceased to be Director on 11 Jun 2019.
3 earlier events are in the company report.
Frequently asked questions
Jorkar Pharmaceuticals is an active private limited company based in Delhi, India. The company works in real estate financing, within the financial services industry. It was incorporated on 13 December 2005 (21+ years old) and is registered under CIN U24232DL2005PTC143593.
Jorkar Pharmaceuticals has 2 current directors:
- Manju Rani - Director
- Krishna Devi - Director
The latest financial statements of Jorkar Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Jorkar Pharmaceuticals is U24232DL2005PTC143593. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jorkar Pharmaceuticals has 1 court case on record: 1 filed against it.
Jorkar Pharmaceuticals was incorporated on 13 December 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Jorkar Pharmaceuticals by revenue are Smooth Trading Private Limited, Homelike Motels and Resorts Private Limited, Satyaraj Warehousings Pvt Ltd, Sakambhari Merchandise Private Limited, Everest Pharmaceuticals Pvt Ltd and 5 more, all in the BFSI industry (Machinery and Equipment Leasing, Pharmaceuticals, Real Estate Leasing).
Jai Pal Singh ceased to be Director on 11 Jun 2019. Manju Rani was appointed as Director on 11 Jun 2019. Krishna Devi ceased to be Additional Director on 30 Sep 2011. Jorkar Pharmaceuticals has 5 board changes on record in total.
The registered office of Jorkar Pharmaceuticals is at House No. 163A Ground Floor Shop No. 2 Shahpur Jat, Delhi, India – 110049.
Jorkar Pharmaceuticals operates in the financial services industry, in the real estate financing segment.
Jorkar Pharmaceuticals has open charges of ₹2.41 Cr and satisfied charges of ₹1.45 Cr as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
